Innate Pharma S.A.
Hedge Funds Holdings

Last updated:

Innate Pharma S.A.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0.34% of the total amount of its stocks outstanding. This makes up a total of 272.51K shares of Innate Pharma S.A.. Compared to the previous quarter, the number fell by -31.83% or -127.24K shares fewer. As for the holding position changes, 50% (2) of current hedge fund investors increased the number of shares held, 25% (1) of current holders sold a part of the shares held, and 50% (2) closed the holdings completely.

Hedge funds holding Innate Pharma S.A. (Q1 2016 – Q1 2023)

Number of hedge funds
Q1 2016 0
Q2 2018 1
Q3 2018 0
Q4 2019 12
Q1 2020 10
Q2 2020 7
Q3 2020 6
Q4 2020 4
Q1 2021 7
Q2 2021 5
Q3 2021 18
Q4 2021 15
Q1 2022 12
Q2 2022 12
Q3 2022 9
Q4 2022 10
Q1 2023 4

Hedge funds changes in Innate Pharma S.A. positions (Q1 2016 – Q1 2023)

Changes in positions
Q1 2016 0001-1
Q2 2018 10000
Q3 2018 0001-1
Q4 2019 120000
Q1 2020 3154-3
Q2 2020 02023
Q3 2020 01212
Q4 2020 0122-1
Q1 2021 4121-1
Q2 2021 0042-1
Q3 2021 132300
Q4 2021 4557-6
Q1 2022 2355-3
Q2 2022 3343-1
Q3 2022 1344-3
Q4 2022 4143-2
Q1 2023 0212-1

Top 50 hedge fund holders of Innate Pharma S.A. (NASDAQ:IPHA)

Hedge fund Value Shares owned Portfolio share
BLACKROCK INC. Larry Fink 965K 482.64K 0.000%
OPTIVER HOLDING B.V. 371K 185.31K 0.000%
BANK OF AMERICA CORP /DE/ 330K 164.77K 0.000%
MORGAN STANLEY 114K 56.85K 0.000%
TWO SIGMA INVESTMENTS, LP John Overdeck 38K 18.78K 0.000%
BALYASNY ASSET MANAGEMENT L.P. Dmitry Balyasny 32K 16.09K 0.000%
MILLENNIUM MANAGEMENT LLC Israel Englander 29K 14.63K 0.000%
UBS GROUP AG 9K 4.50K 0.000%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 1K 500 0.000%
CAPTRUST FINANCIAL ADVISORS 0 0 0.000%
CREDIT SUISSE AG/ 0 0 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 0 0 0.000%
BARCLAYS PLC 0 0 0.000%